title: Intravenous immunoglobulin in the treatment of severe clostridium difficile colitis.
abstract: Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated with IVIG with a review of the medical literature to identify the optimal timing and clinical characteristics for this treatment strategy.
authors.affiliation: Department of Gastroenterology, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA.
authors.forename: Nihar
authors.initials: N
authors.lastname: Shah
authors.affiliation: Department of Infectious Diseases, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA.
authors.forename: Hamid
authors.initials: H
authors.lastname: Shaaban
authors.affiliation: Department of Gastroenterology, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Spira
authors.affiliation: Department of Infectious Diseases, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA.
authors.forename: Jihad
authors.initials: J
authors.lastname: Slim
authors.affiliation: Department of Infectious Diseases, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA.
authors.forename: Jack
authors.initials: J
authors.lastname: Boghossian
keywords: Clostridium difficile; Colitis; Intravenous immunoglobulin